Steroid treatment for severe psittacosis pneumonia in the ICU
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether giving corticosteroids (anti-inflammatory medicines) to adults with severe psittacosis pneumonia in the ICU can help them recover better. It aims to see if this treatment reduces the need for breathing support or improves survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the intensive care unit (ICU)
- You have severe pneumonia (e.g., needing a breathing tube or blood pressure support, or having several serious symptoms)
- A test (like PCR or next-generation sequencing) has confirmed the pneumonia is caused by psittacosis bacteria
- You have not been on vasopressors for septic shock yet
- You are not already taking high-dose steroids, are not pregnant or breastfeeding, and have no other exclusions (like active bleeding or certain infections)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving steroids (anti-inflammatory medicines) to people with a severe lung infection called Pneumocystis pneumonia (PJP) can improve outcomes. It is for patients who are in the ICU and do not have HIV, which is a different group than typical PJP patients.
This study tests whether a steroid medicine can help adults in the ICU with severe flu pneumonia recover better. If you qualify, you may receive either the steroid or a placebo (dummy treatment) to see if it reduces inflammation and improves breathing.
This trial tests whether steroids (corticosteroids) can help adults with severe pneumonia caused by adenovirus (a common virus) who are in the ICU. The goal is to see if steroids reduce inflammation and improve recovery.
This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.
This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.
This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.
Hear when a new Psittacosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.